| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 200,772 | | Cost of Revenue | 17,888 | | | Gross Profit | 182,884 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 8,045 | | Non Recurring | 565 | | Others | 10,614 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 163,660 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (27,926) | | Earnings Before Interest And Taxes | 135,734 | | Interest Expense | 16,523 | | Income Before Tax | 119,211 | | Income Tax Expense |
-
| | Minority Interest |
-
| | | | Net Income From Continuing Ops | 119,211 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 119,211 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $119,211 |
|
0.22% Nasdaq 
0.07 (0.78%) 
Income Statement
